08:58 AM EDT, 06/26/2025 (MT Newswires) -- Health care stocks were steady pre-bell Thursday with the iShares Biotechnology ETF (IBB) inactive and the Health Care Select Sector SPDR Fund (XLV) up a slight 0.1% recently.

Theravance Biopharma ( TBPH ) shares were more than 4% higher after the company said Viatris has received regulatory approval in China for Yupelri, a once-daily nebulized treatment for chronic obstructive pulmonary disease.